Aragen receives SBTi approval for its greenhouse gas emission reduction targets
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
The company also reported significant progress toward its internally defined Sustainable Development Goals
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
The net-zero target approval complements the company's near-term emission reduction targets
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
Subscribe To Our Newsletter & Stay Updated